This article is more than 5 years old. Information may no longer be current.
AGA, Takeda announce three new grants to support young IBD researchers
Click Here to Manage Email Alerts
The AGA is accepting applications for three new research grants funded by Takeda to support young researchers studying inflammatory bowel disease, according to a press release.
“The AGA Research Foundation is very grateful to have Takeda’s support for promising young researchers at a very vulnerable stage in their careers,” Robert S. Sandler, MD, MPH, AGAF, chair of the AGA Research Foundation, said in the press release. “Inflammatory bowel disease offers exciting opportunities for research, and we look forward to seeing how these three award recipients will advance our understanding of this serious digestive disease.”
The AGA-Takeda Pharmaceuticals Research Scholar Awards in Inflammatory Bowel Disease will grant $90,000 annually for 3 years beginning July 2017 to three young IBD researchers focused on projects with the potential to improve patient care, with the objective of helping them develop independent research careers by protecting a major proportion of their time for research.
Investigators in the early years of their careers who have demonstrated “exceptional promise” and research achievements can apply at the AGA website by August 26, 2016.
“As we look to the future, there is great promise with significant IBD research underway, but a strong need still exists for further scientific and clinical understanding,” Karen Lasch, MD, executive medical director, gastroenterology, Takeda, said in the press release. “Providing young research investigators with the support they need to drive innovation and discovery is critical.”
Disclosures: Sandler is chair of the AGA Research Foundation, and Lasch is employed by Takeda.